About Dulaglutide
            
            Class: | GLP-1 receptor agonist  
Use: | Treatment of type 2 diabetes mellitus to improve glycemic control; may also reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.  
Adult dose: | Initial dose of 0.75 mg once weekly; may be increased to 1.5 mg once weekly based on glycemic control and tolerability.  
Pediatric dose: | Safety and efficacy not established in pediatric patients under 18 years of age.  
Side effects: | Nausea, vo
         
        
            
                
                
                    
                        Drug Class
                    
                    GLP-1 receptor agonist
                 
                
                
                    
                        Uses & Indications
                    
                    Treatment of type 2 diabetes mellitus to improve glycemic control; may also reduce the risk of major cardiovascular events in adults with type 2 diabetes and established cardiovascular disease.
                 
                
                
                    
                        Storage Requirements
                    
                    Store in the refrigerator (36°F to 46°F or 2°C to 8°C); may be kept at room temperature (up to 86°F or 30°C) for up to 14 days once removed from the refrigerator.
                 
                
                
                    
                        Manufacturer & Packaging
                    
                    
                        Manufacturer: Eli Lilly & Co Inc., U.S.A
                    
                    
                    Package Size
                    4 Pre-filled Pen
                    
                    
                    Price & Supplier
                    
                        Price in UAE: AED 957.00
                    
                    
                 
             
            
                
                
                    
                        Dosage Information
                    
                    
                        Adult Dose
                    
                    
                        Initial dose of 0.75 mg once weekly; may be increased to 1.5 mg once weekly based on glycemic control and tolerability.
                    
                    
                        Pediatric Dose
                    
                    
                        Safety and efficacy not established in pediatric patients under 18 years of age.
                    
                 
                
                
                    
                        Side Effects
                    
                    Nausea, vomiting, diarrhea, abdominal pain, decreased appetite, injection site reactions, and potential for pancreatitis.
                 
             
         
        
        
            
                Contraindications & Precautions
            
            Personal or family history of medullary thyroid carcinoma or Multiple Endocrine Neoplasia syndrome type 2; hypersensitivity to dulaglutide or any component of the formulation.
         
        
        
            
                Important Warnings
            
            Risk of thyroid C-cell tumors; pancreatitis; renal impairment; hypoglycemia when used with insulin or sulfonylureas; not recommended as first-line therapy for diabetes.
         
        
        
        
        
        
        
        
        
        
        
            
                Medical Disclaimer
            
            
                This information is for educational purposes only and should not replace professional medical advice. 
                Always consult with a licensed healthcare provider or pharmacist in the UAE before taking any medication. 
                The information presented here is specific to medicines available in UAE pharmacies and is regularly updated 
                to ensure accuracy for patients and healthcare professionals in the United Arab Emirates.